Skip to content

Analysis of NMES Effects Using Urinary Exosome Protein Analysis

Analysis of NMES Effects Using Urinary Exosome Protein Analysis - Analysis of NMES Effects Using Urinary Exosome Protein Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000055351
Enrollment
22
Registered
2024-08-28
Start date
2024-08-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the Knee and Osteoarthritis of the Hip

Interventions

Neuromuscular electrical stimulation control

Sponsors

Nippon Sport Science University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Men and women aged 50 and above attending outpatient rehabilitation at the Owl Clinic Jiyugaoka Patients undergoing outpatient musculoskeletal rehabilitation as a treatment for their underlying condition Undergoing musculoskeletal rehabilitation for osteoarthritis of the knee and osteoarthritis of the hip Started outpatient rehabilitation within the last six months

Exclusion criteria

Exclusion criteria: Patients currently undergoing treatment for malignant tumors (a history of malignancy is not an issue). Patients with severe diabetes (complications such as retinopathy, fundus hemorrhage, dialysis, or peripheral neuropathy). Patients with severe heart disease (e.g., in the ultra-acute phase of acute myocardial infarction, those with a pacemaker, unstable angina, poorly controlled heart failure, advanced obstructive hypertrophic cardiomyopathy, acute embolism, or acute infections such as pericarditis or myocarditis). Patients with severe dementia who cannot follow instructions.

Design outcomes

Primary

MeasureTime frame
Analysis of Urinary Exosomes: The analysis of proteins within the isolated exosomes will focus on the expression levels of Parkin, a key regulator of mitophagy; GDF-8, which functions as a negative regulator of muscle growth; and Activin II receptor, expected to be expressed on the outer membrane of exosomes and reflect the condition of skeletal muscle, both before and after NMES.

Countries

Japan

Contacts

Public Contactmitsuo Hashimoto

Nippon Sport Science University Faculty of Sport Science, Department of Health Science

mitsuo-hashimoto@nittai.ac.jp03-5706-0862

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026